Based on our investigation, the alpha satellite RNA level can complement PSA as a biomarker for monitoring the progression of metastatic prostate cancer and for the diagnosis of metastatic castration-resistant stage of disease. This evidence concerns the gene KLK3 and metastatic prostate carcinoma.